Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Advances in Local-Regional Therapies for HCC

April 22nd 2016

Major Advances in Treatment of Hepatitis C Virus

April 22nd 2016

Assessing Response to Sorafenib in Liver Cancers

April 22nd 2016

Managing Toxicities in Advanced HCC

April 22nd 2016

Practical Views on Sorafenib in HCC

April 22nd 2016

Systemic Therapy for Advanced HCC

April 22nd 2016

Radiographic Monitoring after Treatment in HCC

April 22nd 2016

Radioembolization in HCC

April 22nd 2016

Chemoembolization in Hepatocellular Carcinoma

April 22nd 2016

Resectability of HCC

April 22nd 2016

Diagnostic Workup for HCC

April 22nd 2016

Risk Factors for Hepatocellular Carcinoma

April 22nd 2016

Multidisciplinary Care in Hepatocellular Carcinoma

April 22nd 2016

Using Multiple Biomarkers Improves Risk Prediction for Breast Cancer

April 19th 2016

The addition of three biological markers to conventional breast cancer risk models significantly improved the ability to distinguish women at high and low risk.

PARP/AKT Inhibitor Combination Active in Multiple Tumor Types

April 18th 2016

The combination of the PARP inhibitor olaparib and the investigational AKT inhibitor AZD5363 resulted in durable responses in patients with solid tumors, with and without BRCA mutations.

Third-Generation EGFR TKIs Move to Frontline in Lung Cancer

April 14th 2016

A new generation of EGFR-targeted TKIs are poised to displace traditional agents as frontline therapies for patients with lung cancer.

Liquid Biopsy Mania Leaves Questions Unanswered

April 14th 2016

Many physicians are excited by the possibility of following the evolving story of their patientsâ€™ cancer no longer through images including PET scans, but through changes in the molecular phenotype of their patientsâ€™ tumors.

Challenging Genomic Blueprint of Head and Neck Cancers Emerges

April 8th 2016

Next-generation sequencing efforts focusing on the most common form, head and neck squamous cell carcinoma, are illuminating the hidden complexities of its genome.

Teaching Points and Conclusions in DTC

April 1st 2016

Emerging Therapies in Differentiated Thyroid Cancer

April 1st 2016